FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015778075> ?p ?o ?g. }

• W2015778075 endingPage "2687" @default.
• W2015778075 startingPage "2680" @default.
• W2015778075 abstract "Background— Stroke is a debilitating condition with an increased risk in patients with atrial fibrillation. Although data from clinical trials suggest that both rate and rhythm control are acceptable approaches with comparable rates of mortality in the short term, it is unclear whether stroke rates differ between patients who filled prescriptions for rhythm or rate control therapy. Methods and Results— We conducted a population-based observational study of Quebec patients ≥65 years with a diagnosis of atrial fibrillation during the period 1999 to 2007 with the use of linked administrative data from hospital discharge and prescription drug claims databases. We compared rates of stroke or transient ischemic attack (TIA) among patients using rhythm (class Ia, Ic, and III antiarrhythmics), versus rate control (β-blockers, calcium channel blockers, and digoxin) treatment strategies (either current or new users). The cohort consisted of 16 325 patients who filled a prescription for rhythm control therapy (with or without rate control therapy) and 41 193 patients who filled a prescription for rate control therapy, with a mean follow-up of 2.8 years (maximum 8.2 years). A lower proportion of patients on rhythm control therapy than on rate control therapy had a CHADS 2 (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and previous stroke or TIA) score of ≥2 (58.1% versus 67.0%, P <0.001). Treatment with any antithrombotic drug was comparable in the 2 groups (76.8% in rhythm control versus 77.8% in rate control group). Crude stroke/TIA incidence rate was lower in patients treated with rhythm control in comparison with rate control therapy (1.74 versus 2.49, per 100 person-years, P <0.001). This association was more marked in patients in the moderate- and high-risk groups for stroke according to the CHADS 2 risk score. In multivariable Cox regression analysis, rhythm control therapy was associated with a lower risk of stroke/TIA in comparison with rate control therapy (adjusted hazard ratio, 0.80; 95% confidence interval, 0.74, 0.87). The lower stroke/TIA rate was confirmed in a propensity score–matched cohort. Conclusions— In comparison with rate control therapy, the use of rhythm control therapy was associated with lower rates of stroke/TIA among patients with atrial fibrillation, in particular, among those with moderate and high risk of stroke." @default.
• W2015778075 created "2016-06-24" @default.
• W2015778075 creator A5004859111 @default.
• W2015778075 creator A5015069596 @default.
• W2015778075 creator A5017235084 @default.
• W2015778075 creator A5037490018 @default.
• W2015778075 creator A5039870075 @default.
• W2015778075 creator A5063041093 @default.
• W2015778075 creator A5068138290 @default.
• W2015778075 creator A5069697993 @default.
• W2015778075 creator A5072116483 @default.
• W2015778075 date "2012-12-04" @default.
• W2015778075 modified "2023-10-15" @default.
• W2015778075 title "Rhythm Versus Rate Control Therapy and Subsequent Stroke or Transient Ischemic Attack in Patients With Atrial Fibrillation" @default.
• W2015778075 cites W1519386588 @default.
• W2015778075 cites W1625841550 @default.
• W2015778075 cites W1971505725 @default.
• W2015778075 cites W1985272109 @default.
• W2015778075 cites W1989801282 @default.
• W2015778075 cites W1994231358 @default.
• W2015778075 cites W1999468381 @default.
• W2015778075 cites W2008237495 @default.
• W2015778075 cites W2020346401 @default.
• W2015778075 cites W2046141117 @default.
• W2015778075 cites W2062786076 @default.
• W2015778075 cites W2070654626 @default.
• W2015778075 cites W2074334843 @default.
• W2015778075 cites W2086820273 @default.
• W2015778075 cites W2090208107 @default.
• W2015778075 cites W2110159059 @default.
• W2015778075 cites W2110253 @default.
• W2015778075 cites W2114775432 @default.
• W2015778075 cites W2116312562 @default.
• W2015778075 cites W2124805101 @default.
• W2015778075 cites W2128106558 @default.
• W2015778075 cites W2132505348 @default.
• W2015778075 cites W2144891869 @default.
• W2015778075 cites W2151074096 @default.
• W2015778075 cites W2161515661 @default.
• W2015778075 cites W2162131419 @default.
• W2015778075 cites W2162586165 @default.
• W2015778075 cites W2162871344 @default.
• W2015778075 cites W2163864813 @default.
• W2015778075 cites W2164238702 @default.
• W2015778075 cites W4210323412 @default.
• W2015778075 doi "https://doi.org/10.1161/circulationaha.112.092494" @default.
• W2015778075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23124034" @default.
• W2015778075 hasPublicationYear "2012" @default.
• W2015778075 type Work @default.
• W2015778075 sameAs 2015778075 @default.
• W2015778075 citedByCount "108" @default.
• W2015778075 countsByYear W20157780752013 @default.
• W2015778075 countsByYear W20157780752014 @default.
• W2015778075 countsByYear W20157780752015 @default.
• W2015778075 countsByYear W20157780752016 @default.
• W2015778075 countsByYear W20157780752017 @default.
• W2015778075 countsByYear W20157780752018 @default.
• W2015778075 countsByYear W20157780752019 @default.
• W2015778075 countsByYear W20157780752020 @default.
• W2015778075 countsByYear W20157780752021 @default.
• W2015778075 countsByYear W20157780752022 @default.
• W2015778075 countsByYear W20157780752023 @default.
• W2015778075 crossrefType "journal-article" @default.
• W2015778075 hasAuthorship W2015778075A5004859111 @default.
• W2015778075 hasAuthorship W2015778075A5015069596 @default.
• W2015778075 hasAuthorship W2015778075A5017235084 @default.
• W2015778075 hasAuthorship W2015778075A5037490018 @default.
• W2015778075 hasAuthorship W2015778075A5039870075 @default.
• W2015778075 hasAuthorship W2015778075A5063041093 @default.
• W2015778075 hasAuthorship W2015778075A5068138290 @default.
• W2015778075 hasAuthorship W2015778075A5069697993 @default.
• W2015778075 hasAuthorship W2015778075A5072116483 @default.
• W2015778075 hasBestOaLocation W20157780751 @default.
• W2015778075 hasConcept C126322002 @default.
• W2015778075 hasConcept C127413603 @default.
• W2015778075 hasConcept C134018914 @default.
• W2015778075 hasConcept C164705383 @default.
• W2015778075 hasConcept C2426938 @default.
• W2015778075 hasConcept C2775914520 @default.
• W2015778075 hasConcept C2777015399 @default.
• W2015778075 hasConcept C2777707475 @default.
• W2015778075 hasConcept C2778094803 @default.
• W2015778075 hasConcept C2778198053 @default.
• W2015778075 hasConcept C2779161974 @default.
• W2015778075 hasConcept C2779518148 @default.
• W2015778075 hasConcept C2780645631 @default.
• W2015778075 hasConcept C2908647359 @default.
• W2015778075 hasConcept C555293320 @default.
• W2015778075 hasConcept C71924100 @default.
• W2015778075 hasConcept C78519656 @default.
• W2015778075 hasConcept C98274493 @default.
• W2015778075 hasConcept C99454951 @default.
• W2015778075 hasConceptScore W2015778075C126322002 @default.
• W2015778075 hasConceptScore W2015778075C127413603 @default.
• W2015778075 hasConceptScore W2015778075C134018914 @default.
• W2015778075 hasConceptScore W2015778075C164705383 @default.
• W2015778075 hasConceptScore W2015778075C2426938 @default.
• W2015778075 hasConceptScore W2015778075C2775914520 @default.

• next